Meeting
2024 ASCO Genitourinary Cancers Symposium
Survival and comorbid diabetes mellitus in metastatic hormone-sensitive prostate cancer.
Authors
Priya Baxi
Saint Louis University School of Medicine, St. Louis, MO
Priya Baxi , Daniel B. Eaton Jr., Varun Puri , Martin W. Schoen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 74)
DOI
10.1200/JCO.2024.42.4_suppl.74
Abstract #
74
Poster Bd #
C9
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Cardiovascular medications and overall survival in metastatic hormone-sensitive prostate cancer.
First Author: Kara Ingram
First Author: Philippe Autier
Poster
2024 ASCO Breakthrough
Opioid access barriers for cancer pain relief in Vietnam: A qualitative study.
First Author: Trang Nguyen
Poster
2024 ASCO Annual Meeting
Real-world risk of bleeding events in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with BTKi.
First Author: Javid J. Moslehi